Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 49, 2019 - Issue 12
253
Views
8
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

LC-MS/MS detection of citrus unshiu peel-derived flavonoids in the plasma and brain after oral administration of yokukansankachimpihange in rats

, &
Pages 1494-1503 | Received 20 Dec 2018, Accepted 07 Feb 2019, Published online: 04 Mar 2019

References

  • Aizawa R, Kanbayashi T, Saito Y, et al. (2002). Effects of Yoku-kan-san-ka-chimpi-hange on the sleep of normal healthy adult subjects. Psychiatry Clin Neurosci 56:303–4.
  • Cantelli-Forti G, Maffei F, Hrelia P, et al. (1994). Interaction of licorice on glycyrrhizin pharmacokinetics. Environ Health Perspect 102: 65–8.
  • Cho J. (2006). Antioxidant and neuroprotective effects of hesperidin and its aglycone hesperetin. Arch Pharm Res 29:699–706.
  • Chtourou Y, Slima AB, Gdoura R, Fetoui H. (2015). Naringenin mitigates iron-induced anxiety-like behavioral impairment, mitochondrial dysfunctions, ectonucleotidases and acetylcholinesterase alteration activities in rat hippocampus. Neurochem Res 40:1563–75.
  • Egashira N, Mishima K, Kurauchi K, et al. (2001). Cholinergic involvement in the improving effects of Yoku-kan-san-ka-chimpi-hange (Yi-Gan-San-Jia-Chen-Pi-Ban-Xia) on the disruption of spatial cognition and the electroconvulsive shock-induced immobilization. J Trad Med 18:71–80.
  • Fujita T, Kawase A, Nishijima N, et al. (2008). Gastrointestinal absorption of hesperidin and hesperetin after oral administration of immature Citrus unshiu extract to rats. Jpn J Pharmacogn 62:8–14.
  • Furukawa Y, Okuyama S, Amakura Y, et al. (2012). Isolation and characterization of activators of ERK/MAPK from citrus plants. Int J Mol Sci 13:1832–45.
  • Hamaguchi T, Tsutsui-Kimura I, F.T K, Mimura M. (2017). Yokukansankachimpihange increased body weight but not food-incentive motivation in wild-type mice. Nagoya J Med Sci 79:351–62.
  • Hwang SL, Shih PH, Yen GC. (2012). Neuroprotective effects of citrus flavonoids. J Agric Food Chem 60:877–85.
  • Hyde AJ, May BH, Dong L, et al. (2017). Herbal medicine for management of the behavioural and psychological symptoms of dementia (BPSD): a systematic review and meta-analysis. J Psychopharmacol 31:169–83.
  • Iizuka S, Kawakami Z, Imamura S, et al. (2010). Electron-microscopic examination of effects of yokukansan, a traditional Japanese medicine, on degeneration of cerebral cells in thiamine-deficient rats. Neuropathology 30:524–36.
  • Ikarashi Y, Iizuka S, Imamura S, et al. (2009). Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiamine-deficient rats. Biol Pharm Bull 32:1701–9.
  • Ikarashi Y, Mizoguchi K. (2016). Neuropharmacological efficacy of the traditional Japanese Kampo medicine yokukansan and its active ingredients. Pharmacol Ther 166:84–95.
  • Ikarashi Y, Sekiguchi K, Mizoguchi K. (2018). Serotonin receptor binding characteristics of geissoschizine methyl ether, an indole alkaloid in Uncaria hook. Curr Med Chem 25:1036–45.
  • Imamura S, Tabuchi M, Kushida H, et al. (2011). The blood-brain barrier permeability of geissoschizine methyl ether in Uncaria hook, a galenical constituent of the traditional Japanese medicine yokukansan. Cell Mol Neurobiol 31:787–93.
  • Ito A, Shin N, Tsuchida T, et al. (2013). Antianxiety-like effects of Chimpi (dried citrus peels) in the elevated open-platform test. Molecules 18:10014–23.
  • Kasahara Y, Saito E, Hikino H. (1983). Pharmacological actions of Pinellia tubers and zingiber rhizomes. Jpn J Pharmacog 37:73–83.
  • Kitagawa H, Munekage M, Ichikawa K, et al. (2015). Pharmacokinetics of active components of yokukansan, a traditional Japanese herbal medicine after a single oral administration to healthy Japanese volunteers: a cross-over, randomized study. PLoS One 10:e0131165.
  • Kitagawa H, Munekage M, Matsumoto T, et al. (2015). Pharmacokinetic profiles of active ingredients and its metabolites derived from rikkunshito, a ghrelin enhancer, in healthy Japanese volunteers: a cross-over, randomized study. PLoS One 10:e0133159.
  • Kushida H, Fukutake M, Tabuchi M, et al. (2013). Simultaneous quantitative analyses of indole and oxindole alkaloids of Uncaria Hook in rat plasma and brain after oral administration of the traditional Japanese medicine Yokukansan using high-performance liquid chromatography with tandem mass spectrometry. Biomed Chromatogr 27:1647–56.
  • Kushida H, Matsumoto T, Igarashi Y, et al. (2015). Metabolic profiling of the Uncaria hook alkaloid geissoschizine methyl ether in rat and human liver microsomes using high-performance liquid chromatography with tandem mass spectrometry. Molecules 20:2100–14.
  • Lyu JH, Lee HT. (2013). Effects of dried Citrus unshiu peels on gastrointestinal motility in rodents. Arch Pharm Res 36:641–8.
  • Maruno M. (1997). Research for active principles of Pinelliae tuber and new preparation of crude drug. J Trad Med 14:81–8.
  • Matsuda Y, Kishi T, Shibayama H, Iwata N. (2013). Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta-analysis of randomized controlled trials. Hum Psychopharmacol 28:80–6.
  • Matsui E, Takayama K, Sato E, Okamura N. (2011). The influence of glycyrrhiza and antibiotics on the purgative action of sennoside a from Daiokanzoto in mice. Biol Pharm Bull 34:1438–42.
  • Matsumoto H, Ikoma Y, Sugiura M, et al. (2004). Identification and quantification of the conjugated metabolites derived from orally administered hesperidin in rat plasma. J Agric Food Chem 52:6653–9.
  • Matsuzaki K, Yamakuni T, Hashimoto M, et al. (2006). Nobiletin restoring β-amyloid-impaired CREB phosphorylation rescues memory deterioration in Alzheimer's disease model rats. Neurosci Lett 400:230–4.
  • Mizoguchi K, Ikarashi Y. (2017). Cellular pharmacological effects of the traditional Japanese Kampo medicine yokukansan on brain cells. Front Pharmacol 8:655.
  • Mizuhara Y, Takizawa Y, Ishihara K, et al. (2005). The influence of the sennosides on absorption of glycyrrhetic acid in rats. Biol Pharm Bull 28:1897–902.
  • Nagase H, Omae N, Omori A, et al. (2005). Nobiletin and its related flavonoids with CRE-dependent transcription-stimulating and neuritegenic activities. Biochem Biophys Res Commun 337:1330–6.
  • Nagata K, Yokoyama E, Yamazaki T, et al. (2012). Effects of yokukansan on behavioral and psychological symptoms of vascular dementia: an open-label trial. Phytomedicine 19:524–8.
  • Nakajima A, Yamakuni T, Haraguchi M, et al. (2007). Nobiletin, a citrus flavonoid that improves memory impairment, rescues bulbectomy-induced cholinergic neurodegeneration in mice. J Pharmacol Sci 105:122–6.
  • Nakajima A, Yamakuni T, Matsuzaki K, et al. (2007). Nobiletin, a citrus flavonoid, reverses learning impairment associated with N-methyl-D-aspartate receptor antagonism by activation of extracellular signal-regulated kinase signaling. J Pharmacol Exp Ther 321:784–90.
  • Niijima A, Okui Y, Kubo M, et al. (1993). Effect of Pinellia ternata tuber on the efferent activity of the gastric vagus nerve in the rat. Brain Res Bull 32:103–6.
  • Okuyama S, Shimada N, Kaji M, et al. (2012). Heptamethoxyflavone, a citrus flavonoid, enhances brain-derived neurotrophic factor production and neurogenesis in the hippocampus following cerebral global ischemia in mice. Neurosci Lett 528:190–5.
  • Onozuka H, Nakajima A, Matsuzaki K, et al. (2008). Nobiletin, a citrus flavonoid, improves memory impairment and Aβ pathology in a transgenic mouse model of Alzheimer's disease. J Pharmacol Exp Ther 326:739–44.
  • Ploeger B, Mensinga T, Sips A, et al. (2001). The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. Drug Metab Rev 33:125–47.
  • Roohbakhsh A, Parhiz H, Soltani F, et al. (2014). Neuropharmacological properties and pharmacokinetics of the citrus flavonoids hesperidin and hesperetin: a mini-review. Life Sci 113:1–6.
  • Sato N, Seiwa C, Uruse M, et al. (2011). Administration of chinpi, a component of the herbal medicine ninjin-youei-to, reverses age-induced demyelination. Evid Based Complement Alternat Med 2011:1.
  • Shinozaki A, Misawa K, Ikeda Y, et al. (2017). Potent effects of flavonoid nobiletin on amplitude, period, and phase of the circadian clock rhythm in PER2::LUCIFERASE mouse embryonic fibroblasts. PLoS One 12:e0170904.
  • Tabuchi M, Imamura S, Kawakami Z, et al. (2012). The blood-brain barrier permeability of 18β-glycyrrhetinic acid, a major metabolite of glycyrrhizin in Glycyrrhiza root, a constituent of the traditional Japanese medicine yokukansan. Cell Mol Neurobiol 32:1139–46.
  • Tabuchi M, Mizuno K, Mizoguchi K, et al. (2017). Yokukansan and yokukansankachimpihange ameliorate aggressive behaviors in rats with cholinergic degeneration in the nucleus basalis of meynert. Front Pharmacol 8:235.
  • Tabuchi M, Yamaguchi T, Iizuka S, et al. (2009). Ameliorative effects of yokukansan, a traditional Japanese medicine, on learning and non-cognitive disturbances in the Tg2576 mouse model of Alzheimer's disease. J Ethnopharmacol 122:157–62.
  • The Food and Drug Administration, 2018. Bioanalytical Method Validation Guidance for Industry. https://www.fda.gov/downloads/drugs/guidances/ucm070107.pdf.
  • The Ministry of Health, Labour, and Welfare (MHLW), 2016. Japanese Pharmacopoeia 17th edition: the MHLW Ministerial Notification No. 64. https://www.mhlw.go.jp/file/06-Seisakujouhou-11120000-Iyakushokuhinkyoku/JP17_REV.pdf
  • Tokunaga H, Seiwa C, Yoshioka N, et al. (2016). An extract of Chinpi, the dried peel of the citrus fruit unshiu, enhances axonal remyelination via promoting the proliferation of oligodendrocyte progenitor cells. Evid Based Complement Alternat Med 2016:1.
  • Yamakuni T, Nakajima A, Ohizumi Y. (2008). Pharmacological action of nobiletin, a component of AURANTII NOBILIS PERICARPIUM with anti-dementia activity, and its application for development of functional foods. Nihon Yakurigaku Zasshi 132:155–9.
  • Yamakuni T, Nakajima A, Ohizumi Y. (2010). Preventive action of nobiletin, a constituent of AURANTII NOBILIS PERICARPIUM with anti-dementia activity, against amyloid-β peptide-induced neurotoxicity expression and memory impairment. Yakugaku Zasshi 130:517–20.
  • Yamamoto Y, Shioda N, Han F, et al. (2009). Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation. Brain Res 1295:218–29.
  • Yang Y, Bai L, Li X, et al. (2014). Transport of active flavonoids, based on cytotoxicity and lipophilicity: an evaluation using the blood-brain barrier cell and Caco-2 cell models. Toxicol in vitro 28:388–96.
  • Youdim KA, Dobbie MS, Kuhnle G, et al. (2003). Interaction between flavonoids and the blood-brain barrier: in vitro studies. J Neurochem 85:180–92.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.